Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | METAP2 | P50579 | 4/20 | 0.39 |
| ▸ | METAP1 | P53582 | 4/20 | 0.39 |
| ▸ | ACE | P12821 | 5/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.34 |
| ▸ | THPO | P40225 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4956217 | 0.79 | MAPT (0.50) | METAP2METAP1ACEKDM4EMAPT | |
| SCHEMBL14991078 | 0.79 | MAPT (0.50) | METAP2METAP1ACEKDM4EMAPT | |
| SCHEMBL4955844 | 0.79 | ACE (0.46) | METAP2METAP1ACE | |
| SCHEMBL4951978 | 0.78 | METAP2 (0.35) | METAP2METAP1ACETDP1MAPT | |
| SCHEMBL4954319 | 0.78 | NOD1 (0.41) | METAP2METAP1ACEMAPTHDAC2 | |
| SCHEMBL2125799 | 0.78 | KDM4E (0.38) | ACEKDM4EMAPTTHRBALOX15 | |
| SCHEMBL31575454 | 0.77 | — | — | |
| SCHEMBL8345830 | 0.77 | — | — | |
| SCHEMBL4952040 | 0.77 | NOD1 (0.47) | ACEMAPTHDAC2 | |
| SCHEMBL4949670 | 0.77 | NOD1 (0.41) | METAP2METAP1ACEMAPTHDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250041318-A1 | STERILANTS COMPOSITION, KITS AND METHODS OF USE THEREOF | COMMUNITREAT LTD. (IL) | 2025-02-06 | — | — | US | disclosed |
| EP-4440698-A1 | STERILANTS COMPOSITION, KITS AND METHODS OF USE THEREOF | Communitreat Ltd. (IL) | 2024-10-09 | — | — | EP | disclosed |
| WO-2023100184-A1 | STERILANTS COMPOSITION, KITS AND METHODS OF USE THEREOF | COMMUNITREAT LTD. (IL) | 2023-06-08 | — | — | WO | disclosed |
| US-20210289794-A1 | COMPOSITIONS AND RELATED METHODS FOR AGRICULTURE | FLAGSHIP PIONEERING INNOVATIONS V, INC. | 2021-09-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250041318-A1 | STERILANTS COMPOSITION, KITS AND METHODS OF USE THEREOF | NASP, ACR, ALPG | METAP2 3458/4885METAP1 3350/4885ACE 4814/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.